PC3 prostate tumor-initiating cells with molecular profile FAM65Bhigh/MFI2low/LEF1low increase tumor angiogenesis

Molecular Cancer

Volumn 9, Issue , 2010, Pages

  Zhang, Kexiong ^a   Waxman, David J ^a  

^a Boston University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN; LYMPHOID ENHANCER FACTOR 1; VERY LATE ACTIVATION ANTIGEN 2; CD31 ANTIGEN; FAM65B PROTEIN, HUMAN; LEF1 PROTEIN, HUMAN; PROTEIN; TUMOR PROTEIN;

ANGIOGENESIS; ARTICLE; CANCER STEM CELL; CARCINOGENICITY; CASE REPORT; CELL CLONING; CELL DENSITY; CELL STRUCTURE; DOWN REGULATION; DRUG RESISTANCE; FAM65B GENE; GENE; HUMAN; HUMAN CELL; MFI2 GENE; PROSTATE CANCER; SPHEROID CELL; UPREGULATION; ANIMAL; DNA MICROARRAY; FLOW CYTOMETRY; GENETICS; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MOUSE; MOUSE MUTANT; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; POLYMERASE CHAIN REACTION; PROSTATE TUMOR; TUMOR CELL LINE;

MUS;

ANIMALS; ANTIGENS, CD31; CELL LINE, TUMOR; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOID ENHANCER-BINDING FACTOR 1; MALE; MICE; MICE, SCID; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; PROSTATIC NEOPLASMS; PROTEINS;

EID: 78650620820     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-9-319     Document Type: Article

References (63)

1. Visvader JE, Lindeman GJ. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 2008, 8:755-768. 10.1038/nrc2499, 18784658.
2. Boman BM, Wicha MS. Cancer stem cells: a step toward the cure. J Clin Oncol 2008, 26:2795-2799. 10.1200/JCO.2008.17.7436, 18539956.
3. Patrawala L, Calhoun-Davis T, Schneider-Broussard R, Tang DG. Hierarchical organization of prostate cancer cells in xenograft tumors: the CD44+alpha2beta1+ cell population is enriched in tumor-initiating cells. Cancer Res 2007, 67:6796-6805. 10.1158/0008-5472.CAN-07-0490, 17638891.
4. Mimeault M, Hauke R, Mehta PP, Batra SK. Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers. J Cell Mol Med 2007, 11:981-1011. 10.1111/j.1582-4934.2007.00088.x, 17979879.
5. Tang C, Ang BT, Pervaiz S. Cancer stem cell: target for anti-cancer therapy. Faseb J 2007, 21:3777-3785. 10.1096/fj.07-8560rev, 17625071.
6. Maitland NJ, Collins AT. Prostate cancer stem cells: a new target for therapy. J Clin Oncol 2008, 26:2862-2870. 10.1200/JCO.2007.15.1472, 18539965.
7. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003, 100:3983-3988. 10.1073/pnas.0530291100, 153034, 12629218.
8. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997, 3:730-737. 10.1038/nm0797-730, 9212098.
9. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 2005, 65:10946-10951. 10.1158/0008-5472.CAN-05-2018, 16322242.
10. Dalerba P, Dylla SJ, Park IK, Liu R, Wang X, Cho RW, Hoey T, Gurney A, Huang EH, Simeone DM, Shelton AA, Parmiani G, Castelli C, Clarke MF. Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci USA 2007, 104:10158-10163. 10.1073/pnas.0703478104, 1891215, 17548814.
11. O'Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007, 445:106-110.
12. Patrawala L, Calhoun T, Schneider-Broussard R, Li H, Bhatia B, Tang S, Reilly JG, Chandra D, Zhou J, Claypool K, Coghlan L, Tang DG. Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene 2006, 25:1696-1708. 10.1038/sj.onc.1209327, 16449977.
13. Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, Dalerba P, Weissman IL, Clarke MF, Ailles LE. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci USA 2007, 104:973-978. 10.1073/pnas.0610117104, 1783424, 17210912.
14. Ricci-Vitiani L, Lombardi DG, Pilozzi E, Biffoni M, Todaro M, Peschle C, De Maria R. Identification and expansion of human colon-cancer-initiating cells. Nature 2007, 445:111-115. 10.1038/nature05384, 17122771.
15. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB. Identification of human brain tumour initiating cells. Nature 2004, 432:396-401. 10.1038/nature03128, 15549107.
16. Collins AT, Habib FK, Maitland NJ, Neal DE. Identification and isolation of human prostate epithelial stem cells based on alpha(2)beta(1)-integrin expression. J Cell Sci 2001, 114:3865-3872.
17. Kasper S. Characterizing the prostate stem cell. J Urol 2007, 178:375. 10.1016/j.juro.2007.05.031, 17561165.
18. Lee A, Kessler JD, Read TA, Kaiser C, Corbeil D, Huttner WB, Johnson JE, Wechsler-Reya RJ. Isolation of neural stem cells from the postnatal cerebellum. Nat Neurosci 2005, 8:723-729. 10.1038/nn1473, 2377345, 15908947.
19. Richardson GD, Robson CN, Lang SH, Neal DE, Maitland NJ, Collins AT. CD133, a novel marker for human prostatic epithelial stem cells. J Cell Sci 2004, 117:3539-3545. 10.1242/jcs.01222, 15226377.
20. Uchida N, Buck DW, He D, Reitsma MJ, Masek M, Phan TV, Tsukamoto AS, Gage FH, Weissman IL. Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci USA 2000, 97:14720-14725. 10.1073/pnas.97.26.14720, 18985, 11121071.
21. Valdespino V, Tsagozis P, Pisa P. Current perspectives in the treatment of advanced prostate cancer. Med Oncol 2007, 24:273-286. 10.1007/s12032-007-0017-9, 17873302.
22. Lang SH, Frame FM, Collins AT. Prostate cancer stem cells. J Pathol 2009, 217:299-306. 10.1002/path.2478, 2673349, 19040209.
23. Tang DG, Patrawala L, Calhoun T, Bhatia B, Choy G, Schneider-Broussard R, Jeter C. Prostate cancer stem/progenitor cells: identification, characterization, and implications. Mol Carcinog 2007, 46:1-14. 10.1002/mc.20255, 16921491.
24. Hill RP. Identifying cancer stem cells in solid tumors: case not proven. Cancer Res 2006, 66:1891-1895. discussion 1890, 10.1158/0008-5472.CAN-05-3450, 16488984.
25. Ganss R. Tumor stroma fosters neovascularization by recruitment of progenitor cells into the tumor bed. J Cell Mol Med 2006, 10:857-865. 10.1111/j.1582-4934.2006.tb00530.x, 17125590.
26. Klassen H. Recruitment of endogenous neural progenitor cells by malignant neoplasms of the central nervous system. Curr Stem Cell Res Ther 2007, 2:113-119. 10.2174/157488807780599257, 18220896.
27. Locke M, Heywood M, Fawell S, Mackenzie IC. Retention of intrinsic stem cell hierarchies in carcinoma-derived cell lines. Cancer Res 2005, 65:8944-8950. 10.1158/0008-5472.CAN-05-0931, 16204067.
28. Kondo T. Stem cell-like cancer cells in cancer cell lines. Cancer Biomark 2007, 3:245-250.
29. Webber MM, Bello D, Quader S. Immortalized and tumorigenic adult human prostatic epithelial cell lines: characteristics and applications. Part 3. Oncogenes, suppressor genes, and applications. Prostate 1997, 30:136-142. 10.1002/(SICI)1097-0045(19970201)30:2<136::AID-PROS9>3.0.CO;2-M, 9051152.
30. Webber MM, Bello D, Quader S. Immortalized and tumorigenic adult human prostatic epithelial cell lines: characteristics and applications Part 2. Tumorigenic cell lines. Prostate 1997, 30:58-64. 10.1002/(SICI)1097-0045(19970101)30:1<58::AID-PROS9>3.0.CO;2-H, 9018337.
31. Barrandon Y, Green H. Three clonal types of keratinocyte with different capacities for multiplication. Proc Natl Acad Sci USA 1987, 84:2302-2306. 10.1073/pnas.84.8.2302, 304638, 2436229.
32. Li H, Chen X, Calhoun-Davis T, Claypool K, Tang DG. PC3 human prostate carcinoma cell holoclones contain self-renewing tumor-initiating cells. Cancer Res 2008, 68:1820-1825. 10.1158/0008-5472.CAN-07-5878, 18339862.
33. Pfeiffer MJ, Schalken JA. Stem cell characteristics in prostate cancer cell lines. Eur Urol 2010, 57:246-254. 10.1016/j.eururo.2009.01.015, 19200636.
34. Harper LJ, Piper K, Common J, Fortune F, Mackenzie IC. Stem cell patterns in cell lines derived from head and neck squamous cell carcinoma. J Oral Pathol Med 2007, 36:594-603. 10.1111/j.1600-0714.2007.00617.x, 17944752.
35. Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, Jones LW. Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol 1979, 17:16-23.
36. Ma S, Chan KW, Hu L, Lee TK, Wo JY, Ng IO, Zheng BJ, Guan XY. Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology 2007, 132:2542-2556. 10.1053/j.gastro.2007.04.025, 17570225.
37. Chiou SH, Yu CC, Huang CY, Lin SC, Liu CJ, Tsai TH, Chou SH, Chien CS, Ku HH, Lo JF. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin Cancer Res 2008, 14:4085-4095. 10.1158/1078-0432.CCR-07-4404, 18593985.
38. Yu F, Yao H, Zhu P, Zhang X, Pan Q, Gong C, Huang Y, Hu X, Su F, Lieberman J, Song E. let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 2007, 131:1109-1123. 10.1016/j.cell.2007.10.054, 18083101.
39. Ponti D, Costa A, Zaffaroni N, Pratesi G, Petrangolini G, Coradini D, Pilotti S, Pierotti MA, Daidone MG. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 2005, 65:5506-5511. 10.1158/0008-5472.CAN-05-0626, 15994920.
40. Ma S, Chan KW, Lee TK, Tang KH, Wo JY, Zheng BJ, Guan XY. Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations. Mol Cancer Res 2008, 6:1146-1153. 10.1158/1541-7786.MCR-08-0035, 18644979.
41. Jounaidi Y, Hecht JE, Waxman DJ. Retroviral transfer of human cytochrome P450 genes for oxazaphosphorine-based cancer gene therapy. Cancer Res 1998, 58:4391-4401.
42. Holloway MG, Laz EV, Waxman DJ. Codependence of growth hormone-responsive, sexually dimorphic hepatic gene expression on signal transducer and activator of transcription 5b and hepatic nuclear factor 4alpha. Mol Endocrinol 2006, 20:647-660. 10.1210/me.2005-0328, 16239260.
43. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008, 3:1101-1108. 10.1038/nprot.2008.73, 18546601.
44. Holloway MG, Miles GD, Dombkowski AA, Waxman DJ. Liver-specific hepatocyte nuclear factor-4alpha deficiency: greater impact on gene expression in male than in female mouse liver. Mol Endocrinol 2008, 22:1274-1286. 10.1210/me.2007-0564, 2366185, 18276827.
45. Hurt EM, Kawasaki BT, Klarmann GJ, Thomas SB, Farrar WL. CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis. Br J Cancer 2008, 98:756-765. 10.1038/sj.bjc.6604242, 2259168, 18268494.
46. Ma J, Waxman DJ. Dominant effect of antiangiogenesis in combination therapy involving cyclophosphamide and axitinib. Clin Cancer Res 2009, 15:578-588. 10.1158/1078-0432.CCR-08-1174, 2729124, 19147763.
47. Bao S, Wu Q, Li Z, Sathornsumetee S, Wang H, McLendon RE, Hjelmeland AB, Rich JN. Targeting cancer stem cells through L1CAM suppresses glioma growth. Cancer Res 2008, 68:6043-6048. 10.1158/0008-5472.CAN-08-1079, 2739001, 18676824.
48. Woodward WA, Chen MS, Behbod F, Rosen JM. On mammary stem cells. J Cell Sci 2005, 118:3585-3594. 10.1242/jcs.02532, 16105882.
49. Draffin JE, McFarlane S, Hill A, Johnston PG, Waugh DJ. CD44 potentiates the adherence of metastatic prostate and breast cancer cells to bone marrow endothelial cells. Cancer Res 2004, 64:5702-5711. 10.1158/0008-5472.CAN-04-0389, 15313910.
50. Yoon S, Molloy MJ, Wu MP, Cowan DB, Gussoni E. C6ORF32 is upregulated during muscle cell differentiation and induces the formation of cellular filopodia. Dev Biol 2007, 301:70-81. 10.1016/j.ydbio.2006.11.002, 1779902, 17150207.
51. Dakour J, Li H, Morrish DW. PL48: a novel gene associated with cytotrophoblast and lineage-specific HL-60 cell differentiation. Gene 1997, 185:153-157. 10.1016/S0378-1119(96)00587-2, 9055809.
52. Suryo Rahmanto Y, Dunn LL, Richardson DR. The melanoma tumor antigen, melanotransferrin (p97): a 25-year hallmark--from iron metabolism to tumorigenesis. Oncogene 2007, 26:6113-6124. 10.1038/sj.onc.1210442, 17452986.
53. Merrill BJ, Gat U, DasGupta R, Fuchs E. Tcf3 and Lef1 regulate lineage differentiation of multipotent stem cells in skin. Genes Dev 2001, 15:1688-1705. 10.1101/gad.891401, 312726, 11445543.
54. Welte K, Zeidler C, Dale DC. Severe congenital neutropenia. Semin Hematol 2006, 43:189-195. 10.1053/j.seminhematol.2006.04.004, 16822461.
55. Skokowa J, Cario G, Uenalan M, Schambach A, Germeshausen M, Battmer K, Zeidler C, Lehmann U, Eder M, Baum C, Grosschedl R, Stanulla M, Scherr M, Welte K. LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropenia. Nat Med 2006, 12:1191-1197. 10.1038/nm1474, 17063141.
56. Li Y, Wang L, Zhang M, Melamed J, Liu X, Reiter R, Wei J, Peng Y, Zou X, Pellicer A, Garabedian MJ, Ferrari A, Lee P. LEF1 in androgen-independent prostate cancer: regulation of androgen receptor expression, prostate cancer growth, and invasion. Cancer Res 2009, 69:3332-3338. 10.1158/0008-5472.CAN-08-3380, 19351848.
57. Dunn LL, Sekyere EO, Rahmanto YS, Richardson DR. The function of melanotransferrin: a role in melanoma cell proliferation and tumorigenesis. Carcinogenesis 2006, 27:2157-2169. 10.1093/carcin/bgl045, 16704991.
58. Bao S, Wu Q, Sathornsumetee S, Hao Y, Li Z, Hjelmeland AB, Shi Q, McLendon RE, Bigner DD, Rich JN. Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res 2006, 66:7843-7848. 10.1158/0008-5472.CAN-06-1010, 16912155.
59. Folkins C, Shaked Y, Man S, Tang T, Lee CR, Zhu Z, Hoffman RM, Kerbel RS. Glioma tumor stem-like cells promote tumor angiogenesis and vasculogenesis via vascular endothelial growth factor and stromal-derived factor 1. Cancer Res 2009, 69:7243-7251. 10.1158/0008-5472.CAN-09-0167, 19738068.
60. Eyler CE, Rich JN. Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis. J Clin Oncol 2008, 26:2839-2845. 10.1200/JCO.2007.15.1829, 2739000, 18539962.
61. Zhao Y, Dong J, Huang Q, Lou M, Wang A, Lan Q. Endothelial cell transdifferentiation of human glioma stem progenitor cells in vitro. Brain Res Bull 2010, 82:308-312. 10.1016/j.brainresbull.2010.06.006, 20599593.
62. Ikeda K, Nakano R, Uraoka M, Nakagawa Y, Koide M, Katsume A, Minamino K, Yamada E, Yamada H, Quertermous T, Matsubara H. Identification of ARIA regulating endothelial apoptosis and angiogenesis by modulating proteasomal degradation of cIAP-1 and cIAP-2. Proc Natl Acad Sci USA 2009, 106:8227-8232. 10.1073/pnas.0806780106, 2676168, 19416853.
63. Ma J, Waxman DJ. Combination of antiangiogenesis with chemotherapy for more effective cancer treatment. Mol Cancer Ther 2008, 7:3670-3684. 10.1158/1535-7163.MCT-08-0715, 2637411, 19074844.